pREBOA与ER-REBOA对血液利用和复苏需求的影响:一项初步分析
本研究利用美国创伤外科协会主动脉阻断复苏登记(AAST AORTA)全部数据,比较ER-REBOA(n=800)与pREBOA(n=155)患者的复苏需求。两组初始表现除年龄(44岁 vs 40岁,p=0.026)和钝性伤比例(78.4% vs 78.7%,p<0.010)外相似;ER-REBOA组Zone 1阻断更少(65.8% vs 71.7%,p=0.046),部分阻断比例pREBOA组为85%、ER-REBOA组为11%(p<0.050)。ER-REBOA组REBOA时生命体征更差,接受的PRBC、FFP、血小板和晶体液均显著更多(p<0.05),且ARDS和脓毒性休克发生率更高(p<0.05)。作者认为这是首次显示pREBOA、部分阻断与减少血液使用和复苏需求相关,但需进一步前瞻性研究。
要点
- pREBOA组部分阻断比例85%,ER-REBOA组11%(p<0.050)。
- ER-REBOA组Zone 1阻断65.8%,pREBOA组71.7%(p=0.046)。
- ER-REBOA组REBOA时生命体征更差,接受的PRBC、FFP、血小板和晶体液均显著多于pREBOA组(p<0.05)。
- pREBOA组ARDS和脓毒性休克发生率更低(p<0.05)。
- 证据等级为治疗/管理Level IV,作者认为需进一步前瞻性研究。
适用人群与场景
- AAST AORTA登记中接受REBOA的创伤患者,比较ER-REBOA(n=800)与pREBOA(n=155)。
- 两组年龄44岁 vs 40岁(p=0.026),钝性伤比例78.4% vs 78.7%(p<0.010)。
处置流程与药物剂量
- pREBOA-PRO导管可在血流动力学允许时滴定灌注,实现部分阻断。
- 部分阻断在pREBOA组执行于85%的患者,ER-REBOA组为11%(p<0.050)。
研究设计与关键结果
- 研究类型:基于AAST AORTA登记的全部数据比较ER-REBOA与pREBOA的复苏需求,采用非配对t检验。
- ER-REBOA组Zone 1阻断使用更少(65.8% vs 71.7%,p=0.046)。
- ER-REBOA组REBOA时生命体征更差,接受的PRBC、FFP、血小板和晶体液均显著多于pREBOA组(p<0.05)。
- pREBOA组ARDS和脓毒性休克发生率更低(p<0.05)。
证据类型、等级与局限
- 证据类型:基于注册登记的初步分析(pilot analysis);证据等级:治疗/管理Level IV。
- 局限:原文未报告局限性;作者结论指出需进一步前瞻性研究。
对床旁实践的改变
- 作者认为,这是首次显示pREBOA、部分阻断与减少血液使用和复苏需求相关,但需进一步前瞻性研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Partial occlusion of the aorta is a resuscitation technique designed to maximize proximal perfusion while allowing a graduated amount of distal flow to reduce the ischemic sequelae associated with complete aortic occlusion. The pREBOA-PRO catheter affords the ability to titrate perfusion as hemodynamics allows; however, the impact of this new technology for resuscitative endovascular balloon occlusion of the aorta (REBOA) on blood use and other resuscitative requirements is currently unknown. We hypothesize that patients undergoing REBOA with the pREBOA-PRO catheter will utilize partial occlusion, when appropriate, and decrease overall resuscitative requirements when compared to patients undergoing REBOA with the ER-REBOA catheter.
METHODS: The entire American Association for the Surgery of Trauma Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery registry was used to compare resuscitation requirements between all ER-REBOA and pREBOA. Unpaired t tests were used to compare resuscitation strategies including packed red blood cells (PRBCs), fresh frozen plasma (FFP), platelets, cryoprecipitate, crystalloids, and need for pressors.
RESULTS: When comparing ER-REBOA (n = 800) use to pREBOA (n = 155), initial patient presentations were similar except for age (44 years vs. 40 years, p = 0.026) and rates of blunt injury (78.4% vs. 78.7% p < 0.010). Zone 1 occlusion was used less often in ER-REBOA (65.8 vs. 71.7, p = 0.046). Partial occlusion was performed in 85% of pREBOA compared with 11% in ER-REBOA ( p < 0.050). Vitals at the time of REBOA were worse in ER-REBOA and received significantly more units of PRBCs, FFP, platelets, and liters of crystalloids than pREBOA ( p < 0.05). Rates of ARDS and septic shock were lower in pREBOA ( p < 0.05).
CONCLUSION: When comparing pREBOA to ER-REBOA, there has been a rise in Zone 1 and partial occlusion. In our pilot analysis of the Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery registry, there was a reduction in administration of PRBCs, FFP, platelets, and crystalloids. Although further prospective studies are required, this is the first to demonstrate an association between pREBOA, partial occlusion, and reduced blood use and resuscitative requirements.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Meyer CH, Beckett A, Dennis BM, et al. pREBOA versus ER-REBOA impact on blood utilization and resuscitation requirements: A pilot analysis. J Trauma Acute Care Surg. 2024. PMID: 38781026. doi:10.1097/TA.0000000000004391
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。